Pacific Shuanglin Bio-Pharmacy News and Activities

Pacific Shuanglin Bio-Pharmacy is a company listed under the stock ticker 000403 (CN).

View the org chart displaying its 4 main executives

Most searched biographies at Pacific Shuanglin Bio-Pharmacy

• Xiankui Rong, General Manager and Chief Executive Officer
• Shaolan Fu, Chairman of the Board
• Lihao Liu, Director

Create your alert
to follow the executive moves at Pacific Shuanglin Bio-Pharmacy.

Pacific Shuanglin Bio-Pharmacy has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Pacific Shuanglin Bio-Pharmacy

Social media about Pacific Shuanglin Bio-Pharmacy

• Pacific Shuanglin Bio-Pharmacy on Wikipedia, Google News & Yahoo Finance
• Pacific Shuanglin Bio-Pharmacy on LinkedIn, X (Twitter) & YouTube